Bg pattern

SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet: Information for the user

Salbuair 2.5 mg solution for inhalation by nebulizer

Salbutamol sulfate

Read this leaflet carefully before starting to take this medicine, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again. If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet

  1. What is Salbuair 2.5 mg and what is it used for
  2. What you need to know before taking Salbuair 2.5 mg
  3. How to take Salbuair 2.5 mg
  4. Possible side effects
  5. Storage of Salbuair 2.5 mg
  6. Package contents and additional information

1. What is SALBUAIR 2.5 mg and what is it used for

This medicine comes in ampoules containing an aqueous solution for inhalation by nebulizer. Salbuair 2.5 mg contains 2.5 mg of salbutamol (equivalent to 3 mg of salbutamol sulfate) dissolved in 2.5 ml of sterile isotonic saline solution.

The active ingredient of this medicine, salbutamol, belongs to a group of medicines called bronchodilators, which relax the muscles of the airway walls in the lungs. This makes it easier to breathe.

It is indicated for the treatment of chronic bronchospasm (closure of the airways in the lungs) that does not respond to conventional therapy and for the treatment of severe acute asthma.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. BEFORE USING SALBUAIR 2.5 mg.

Do not useSalbuair2.5 mg:

  • If you are allergic (hypersensitive) to salbutamol or any of the other components of Salbuair 2.5 mg.
  • It should not be used during premature labor or threatened abortion.

Be careful with Salbuair2.5 mg

Tell your doctor before starting treatment with this medicine:

  • If you have any heart disease, irregular heartbeat, or angina pectoris.
  • If you have an overactive thyroid gland.
  • If you have high potassium levels in your blood.
  • If you have diabetes.
  • If you have high lactate levels in your blood (lactic acidosis), as an increase in these levels can worsen respiratory problems.
  • If you use salbutamol and ipratropium bromide together, as this combination can cause eye disorders such as angle-closure glaucoma.

Use of other medicines

Tell your doctor or pharmacist if you are taking or have recently taken other medicines, including those purchased without a prescription.

Some medicines may interact with Salbuair 2.5 mg. It is important that you inform your doctor if you are taking any of the following medicines:

  • Medicines containing non-selective beta-blockers, such as propranolol.
  • Certain medicines for treating depression (known as monoamine oxidase inhibitors and tricyclic antidepressants).
  • Medicines containing anticholinergics (used to treat asthma, irritable bowel syndrome, Parkinson's disease, and incontinence).
  • Other medicines that help you breathe more easily, such as terbutaline.

Pregnancy and breastfeeding

Consult your doctor or pharmacist before using any medicine.

If it is necessary to administer Salbuair 2.5 mg during pregnancy or breastfeeding, your doctor will carefully weigh the potential benefits and risks based on the severity of the clinical condition.

Driving and using machines

The effects of Salbuair 2.5 mg on driving and using machines have not been described.

Use in athletes

This medicine contains salbutamol, which can produce a positive result in doping tests (see references in section 4.4 of the technical sheet).

3. How to use SALBUAIR 2.5 mg

Follow the administration instructions for Salbuair 2.5 mg exactly as indicated by your doctor. Consult your doctor or pharmacist if you have any questions.

Salbuair should be used as needed and not on a regular basis.

If your asthma is active (for example, you have symptoms or frequent crises, such as difficulty breathing that makes it hard to speak, eat, or sleep, coughing, wheezing, chest tightness, or limited physical capacity), you should inform your doctor immediately, who may start administering a medicine or increase the treatment dose, such as an inhaled corticosteroid, to control your asthma.

Tell your doctor as soon as possible if your medicine seems to be not working as well as usual (for example, if you need higher doses to relieve your respiratory problems or if your inhaler does not provide relief for at least 3 hours), as your asthma may be worsening and you may need a different medicine.

If you use Salbuair 2.5 mg more than twice a week to treat your asthma symptoms, excluding preventive use before exercise, this indicates poorly controlled asthma and may increase the risk of severe asthma attacks (asthma worsening) that can have serious complications and can be life-threatening. You should contact your doctor as soon as possible to review your asthma treatment.

If you use a daily medicine to reduce inflammation in your lungs, e.g., an "inhaled corticosteroid", it is essential that you continue to use it regularly, even if you feel better.

Use in adults and children:

The recommended dose is 2.5 mg up to four times a day. Your doctor may increase this dose to 5 mg up to four times a day. Your doctor may tell you to use your nebulizer every day regularly or only when you have wheezing or shortness of breath.

Salbuair 2.5 mg should be used with suitable nebulizer devices. The mist produced is inhaled through the mask or mouthpiece. Your doctor will indicate which nebulizer is suitable and how to use it.

Instructions for correct administration of the preparation:

Your medication is for inhalation via a nebulizer, so it should not be injected or swallowed.

Hands holding and separating white tablet blisters and hands opening a blister with a fingernail

  1. Prepare your nebulizer following the manufacturer's instructions and your doctor's instructions. Make sure the nebulizer device is clean.
  1. Take a plastic strip with ampoules from the box, open it, and remove one of the ampoules (Fig. 1). Leave the rest of the ampoules in the strip and return it to the box.
  1. Take the ampoule and open it by twisting the top (Fig. 2).
  1. Unless your doctor gives you other instructions, add all the liquid from the plastic ampoule to the nebulizer solution container.
  1. Use the nebulizer according to your doctor's instructions. Discard the empty plastic ampoule.
  1. After using the nebulizer, clean it according to the manufacturer's instructions.

If you think the effect of Salbuair 2.5 mg is too strong or too weak, tell your doctor or pharmacist.

If you use moreSalbuair2.5 mg than you should

If you use more than you should, you may experience changes in heart rhythm, palpitations, tremors, increased or decreased blood pressure, changes in pulse, angina pectoris, hot flashes, dry mouth, and visual accommodation disorders.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount administered. Contact your doctor or the nearest Hospital Emergency Service. Bring this leaflet or an ampoule of this medicine with you, so the doctor treating you knows what you are taking.

If you forget to use Salbuair 2.5 mg

If you forget to use Salbuair 2.5 mg, use the next dose when it is due or before, in case you start to have difficulty breathing.

Do not take a double dose to make up for forgotten doses.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, Salbuair 2.5 mg can cause side effects, although not everyone gets them.

Although it is not known exactly how often it occurs, some people may occasionally experience chest pain (due to heart problems such as angina pectoris). Tell your doctor if you develop these symptoms while being treated with Salbuair 2.5 mg, but do not stop taking this medicine unless your doctor tells you to.

The following side effects have been reported:

Frequent(affect 1 in 10 people)

  • Headache (cephalalgia)
  • Tremors
  • Tachycardia

Uncommon(affect less than 1 in 100 people)

  • Palpitations
  • Irritation of the mouth and throat
  • Muscle cramps

Rare(affect less than 1 in 1000 people)

  • Low potassium levels in the blood (hypokalemia).
  • Dilation of peripheral blood vessels (peripheral vasodilation).

Very rare(affect less than 1 in 10,000 people)

  • Allergic reactions (hypersensitivity) including angioedema and urticaria, bronchospasm, hypotension, and collapse.
  • Hyperactivity.
  • Cardiac arrhythmias, including atrial fibrillation, supraventricular tachycardia, and extrasystoles (heart rhythm disorders).
  • Paradoxical bronchospasm.

Unknown

  • Myocardial ischemia (lack of blood flow to a part of the heart muscle).
  • Lactic acidosis.

Reporting side effects

If you experience any of the side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines, Website: www.notificaram.es

5. Storage of SALBUAIR 2.5 mg.

Keep this medicine out of the sight and reach of children.

Do not store above 25°C. Store in the outer packaging to protect from light.

Discard the ampoules 3 months after opening the aluminum pouch.

The ampoules should be opened immediately before use, and any remaining solution should be discarded.

Do not use Salbuair 2.5 mg after the expiration date shown on the vial after Cad.. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. ADDITIONAL INFORMATION

Composition ofsalbuair2.5 mg

  • The active ingredient is salbutamol sulfate. Each ampoule contains 2.5 mg of salbutamol (equivalent to 3 mg of salbutamol sulfate) dissolved in 2.5 ml of sterile isotonic saline solution.
  • The other ingredients are: sodium chloride, water for injection, and sulfuric acid.

Appearance of the product and package contents:

Salbuair 2.5 mg is presented in strips of 10 ampoules containing a colorless or pale yellow solution inside an aluminum pouch.

Each box contains 60 ampoules.

Marketing authorization holder:

Laboratorio ALDO-UNIÓN, S.L.

Baronesa de Maldá, 73

08950 Esplugues de Llobregat

Barcelona (Spain)

Manufacturer:

Laboratoire Unither

Espace Industriel Nord

151 rue André Durouchez–CS 28028

80084 AMIENS Cedex 2

France

Other presentations:

Salbuair 5 mg solution for inhalation by nebulizer.

This leaflet was approved in June 2013

Online doctors for SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION

Discuss questions about SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION?
SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION?
The active ingredient in SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION is salbutamol. This information helps identify medicines with the same composition but different brand names.
How much does SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION cost in pharmacies?
The average pharmacy price for SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION is around 18.37 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION?
SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION is manufactured by Laboratorio Aldo Union S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to SALBUAIR 2.5 mg SOLUTION FOR NEBULIZER INHALATION?
Other medicines with the same active substance (salbutamol) include SALBUAIR 5 mg SOLUTION FOR NEBULIZER INHALATION, SALBUTAMOL ALDO-UNION 100 micrograms/dose PRESSURIZED INHALER SUSPENSION, SALBUTAMOL NEUTEC 2.5 mg SOLUTION FOR NEBULIZER INHALATION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media